Medical Procedure News

RSS

Bioconnect's Optiflow Vascular Anastomotic System granted CE mark approval

Bioconnect Systems, Inc. today announced CE mark approval for the Optiflow™ Vascular Anastomotic System. The Optiflow™ enhances a surgeon's ability to create precise vascular connections. The initial indication is the creation of an arteriovenous fistula needed for vascular access in hemodialysis patients.

21 Sep 2010

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that it is beginning a development program designed to create a new transdermal biosensor for continuous lactate monitoring to be used in critical care and sports medicine.

21 Sep 2010

Biodegradable polymers represent future of stent design

Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

21 Sep 2010

PROMUS Element Stent receives expanded indications approval for high-risk diabetic and AMI patient groups

Boston Scientific Corporation today announced that its PROMUS® Element™ Everolimus-Eluting Coronary Stent System has received CE Mark approval for use in patients with diabetes and those experiencing an acute myocardial infarction (AMI), or heart attack.

21 Sep 2010

FDA grants orphan drug designation for MultiStem stem cell therapy

Athersys, Inc. announced today that MultiStem, Athersys' multipotent adult progenitor stem cell therapy, has been granted orphan drug designation by the U. S. Food and Drug Administration for the prevention of graft vs. host disease (GvHD).

21 Sep 2010

Paper highlights need for new studies and guidelines around oxygen therapy during MI

The European Society of Cardiology (ESC) welcomes a paper published today in the Journal of the American College of Cardiology (JACC )(1) highlighting concerns over the use of oxygen therapy during MI in patients with normal oxygen levels. The publication adds to calls for revision of the STEMI guidelines around oxygen therapy and for a prospective, large scale randomised trials, issues that were both first raised in a Cochrane Review published in June.

21 Sep 2010

Stanford Cancer Center announces successful treatment of 5,000th patient with CyberKnife system

When Lori Brownell's first tumor appeared − on her left carotid artery − it was surgically removed, leaving an inches-long incision to heal. It was eight years before the feeling returned to that side of her neck, and for a time, she couldn't drive because she couldn't turn her head far enough.

21 Sep 2010

LA surgeon develops minimally invasive approach to remove pineal tumors

One of the most difficult-to-remove tumors located deep in the midbrain area can now be safely excised thanks to the work of one Los Angeles surgeon. Hrayr Shahinian, M.D., medical director of The Skull Base Institute in Los Angeles, has developed a minimally invasive approach to removing pineal tumors so called as they are shaped like pine cones.

21 Sep 2010

Bariatric surgery rates rise among adolescents

According to recent surveys more and more adolescents need bariatric surgery for morbid obesity. This procedure was earlier reserved only for adults. Researchers say that from 2005 to 2007, the rate of gastric banding has jumped nearly seven-fold among youths aged 13 to 20. The process involves placement of a band around the upper part of the stomach using a laparoscope. The study appeared in the journal Pediatrics.

21 Sep 2010

New interventional technique effective for controlling hepatic arterial hemorrhage after PD

Delayed hepatic arterial hemorrhage after pancreaticoduodenectomy (PD) is not a common but a fatal complication, occurring in 7% of all patients. Its ideal management remains unclear and controversial. A research article published on August 7, 2010 in the World Journal of Gastroenterology addresses this question. The authors reported the clinical outcome of 9 patients with life-threatening hemorrhage from a ruptured hepatic artery pseudoaneurysm after PD after treatment with a new interventional technique, namely placement of stent-grafts.

21 Sep 2010

Study: Capecitabine with concurrent radiation is effective for treating gastric cancer

Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined.

21 Sep 2010

FG-4592 oral anemia therapy receives CTA approval from SFDA

FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.

21 Sep 2010

3M Health Care introduces Tegaderm I.V. Advanced Securement Dressing

3M Health Care today announced the launch of 3M™ Tegaderm™ I.V. Advanced Securement Dressing for patients, a comprehensive solution with transparent, breathable film, a stabilization border and new, comfort adhesive technology. The new dressing is perceived by clinicians to reduce catheter manipulation and resist staining which could lead to less frequent dressing changes, and may provide a cost savings option for hospitals.

21 Sep 2010

Corindus announces clinical results of CorPath 200 System

Corindus Vascular Robotics announced the results of the first clinical study of the CorPath 200 System and invites attendees of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference (September 21-25 in Washington, DC) to experience firsthand the CorPath 200 System.

21 Sep 2010

New body-contouring laser causes fat loss

Stephanie Martinez had one of the most universal desires - to shed a few stubborn inches from her waist, hips and thighs - without harsh diets, needles or other surgical interventions that require staying at home and taking time off from work.

20 Sep 2010

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

Vascular Solutions, Inc. and Shepherd Scientific, Inc. today announced they have entered into a distribution agreement providing for Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in the United States. The Angio Assist is an easy-to-use docking station that facilitates the introduction of guide wires into interventional devices including catheters and atherectomy burrs.

20 Sep 2010

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Athena™ programmer, a deep brain stimulation (DBS) therapy management system. This next-generation platform offers clinicians a powerful yet easy-to-use interface that enables them to set or adjust therapeutic parameters to optimize patient results.

20 Sep 2010

Boston Scientific announces acquisition of Asthmatx

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Asthmatx, Inc., a privately held company in Sunnyvale, California. Asthmatx designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma in the 6 to 8 million patients 18 years and older worldwide whose asthma is not well controlled with drugs (inhaled medications).

20 Sep 2010

$Neovasc commences enrollment in Reducer trial for refractory angina$

Neovasc commences enrollment in Reducer trial for refractory angina

Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.

20 Sep 2010

MultiStem multipotent adult progenitor cell therapy preserves 'blood brain barrier'

Athersys, Inc. announced today the publication of a key study in the October issue of Experimental Neurology conducted by researchers at Athersys, the University of Texas Medical School, the Michael E. DeBakey Institute for Comparative Cardiovascular Science and Biomedical Devices, and Texas A&M University.

20 Sep 2010

Medical Procedure News

Bioconnect's Optiflow Vascular Anastomotic System granted CE mark approval

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Biodegradable polymers represent future of stent design

PROMUS Element Stent receives expanded indications approval for high-risk diabetic and AMI patient groups

FDA grants orphan drug designation for MultiStem stem cell therapy

Paper highlights need for new studies and guidelines around oxygen therapy during MI

Stanford Cancer Center announces successful treatment of 5,000th patient with CyberKnife system

LA surgeon develops minimally invasive approach to remove pineal tumors

Bariatric surgery rates rise among adolescents

New interventional technique effective for controlling hepatic arterial hemorrhage after PD

Study: Capecitabine with concurrent radiation is effective for treating gastric cancer

FG-4592 oral anemia therapy receives CTA approval from SFDA

3M Health Care introduces Tegaderm I.V. Advanced Securement Dressing

Corindus announces clinical results of CorPath 200 System

New body-contouring laser causes fat loss

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

St. Jude Medical granted European CE Mark for Athena deep brain stimulation therapy management system

Boston Scientific announces acquisition of Asthmatx

Neovasc commences enrollment in Reducer trial for refractory angina

MultiStem multipotent adult progenitor cell therapy preserves 'blood brain barrier'

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News